ALPHACENTRIC ADVISORS LLC – BioXcel Therapeutics, Inc. Transaction History
ALPHACENTRIC ADVISORS LLC portfolio value:
$591,000
portfolio value
ALPHACENTRIC ADVISORS LLC quarter portfolio value change:
-43.85%
quarter
BioXcel Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -426K | $11.82 | 50K | |
| Q4 2021 | share | Increase | +42.86% | 15K shares | -45K | $21.05 | 50K |
| Q3 2021 | share | Increase | +40.00% | 10K shares | 335K | $30.35 | 35K |
| Q2 2021 | share | 0.00% | 0 shares | -352K | $29.06 | 25K | |
| Q1 2021 | share | 0.00% | 0 shares | -76K | $43.16 | 25K | |
| Q4 2020 | share | Increase | +25.00% | 5K shares | 288K | $46.2 | 25K |
| Q3 2020 | share | Decrease | -20.00% | -5K shares | -458K | $43.36 | 20K |
| Q2 2020 | share | Increase | 0.00% | 25K shares | 1.32M | $53.01 | 25K |